A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been presented by an international team involving researchers at UCL (University College ...

A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB, and that two ...

A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been launched by an international team including researchers from the London School of Hygiene ...

Scientists at Brown University and MIT have figured out how an emerging class of antibiotics binds to the bacterium that causes tuberculosis--a discovery that could lead to new therapeutics to fight ...

Infection by Mycobacterium tuberculosis kills 1.5 million people worldwide every year. Antibiotics to treat TB exist, but in recent years, multi-drug resistant (MDR), extensively drug-resistant (XDR) ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...

(Philadelphia, PA) - A worldwide health problem, tuberculosis kills more people than any other bacterial infection. The World Health Organization estimates that two billion people are infected with TB ...